Precision NeuroMed

PNM is a clinical-stage biotechnology company dedicated to developing cutting-edge technologies that target the underlying causes of brain diseases, not just their symptoms. By addressing the primary barrier to effective therapy—achieving adequate drug delivery to the brain—we strive to dramatically improve patient outcomes and create disease modifying treatments for conditions such as brain tumors, epilepsy, stroke, and neurodegenerative diseases. Learn about how Precision NeuroMed is redefining the future of brain health at www.precisionneuromed.com!